176 related articles for article (PubMed ID: 28571570)
1. Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.
Gomes STM; Gomes ÉR; Dos Santos MB; Lima SS; Queiroz MAF; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; de O Guimarães Ishak M; Ishak R
BMC Infect Dis; 2017 Jun; 17(1):381. PubMed ID: 28571570
[TBL] [Abstract][Full Text] [Related]
2. CCR5∆32 and SDF1 3'A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil.
Lima ÉRG; Queiroz MAF; Lima SS; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; Figueiredo FAPL; Guerreiro JF; Guimarães Ishak MO; Ishak R
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902388
[TBL] [Abstract][Full Text] [Related]
3. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
4. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
5. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
6. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
[TBL] [Abstract][Full Text] [Related]
7. Stromal Cell-Derived Factor-1-3'A Polymorphism Favors HIV-1 Infection in Mexican Women.
Velarde-Félix JS; Cázarez-Salazar SG; Díaz-Camacho SP; Osuna-Ramírez I; Ochoa-Ramírez LA; Sánchez-Zazueta JG; Ramírez M
Intervirology; 2015; 58(6):357-62. PubMed ID: 26859597
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
9. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
[TBL] [Abstract][Full Text] [Related]
10. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
[TBL] [Abstract][Full Text] [Related]
11. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
12. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
Tansiri Y; Rowland-Jones SL; Ananworanich J; Hansasuta P
PLoS One; 2015; 10(3):e0118871. PubMed ID: 25764310
[TBL] [Abstract][Full Text] [Related]
15. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
16. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
[TBL] [Abstract][Full Text] [Related]
17. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
18. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
Gupta A; Padh H
Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
[TBL] [Abstract][Full Text] [Related]
20. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]